1 unchanged sentence
Adoption, Modification or Termination of Rule 10b5-1 Plans and Certain Other Trading Arrangements
−Removed: During the three months ended September 30, 2025, none of our directors or officers adopted, modified or terminated a “Rule 10 b 5 -1 trading arrangement” or “non-Rule 10 b 5 -1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
+Added: During the three months ended March 31, 2026, none of our directors or officers adopted, modified or terminated a “Rule 10 b 5 -1 trading arrangement” or “non-Rule 10 b 5 -1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, except for certain sell-to-cover arrangements with our officers authorizing pre-arranged sales of shares of our common stock to satisfy tax withholding obligations we have arising exclusively from the vesting of RSUs and PSUs.
+Added: The amount of shares to be sold to satisfy our withholding obligations under these arrangements is dependent on future events which cannot be known at this time, including the future trading price of our common stock.
+Added: The expiration date relating to these arrangements is dependent on future events which cannot be known at this time, including the vesting date and any termination of service.
EXHIBIT INDEX
3 unchanged sentences
(incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed on July 7, 2021)
+Added: Second Amendment to Loan and Security Agreement, dated as of January 9, 2026, among the Company, Innovatus Life Sciences Lending Fund I, LP, as the collateral agent and a lender, and the other lenders from time to time party thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on January 12, 2026)
+Added: Form of Performance Stock Unit Agreement (Executives – 2026-2027 Cumulative Revenue) pursuant to 2021 Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on March 3, 2026)
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
13 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto, duly authorized.
−Removed: November 6, 2025
/s/ Kevin Hykes
6 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.